Estradiol is a type of hormone called estrogen. It's important for women's health, especially during their reproductive years. It helps with things like the menstrual cycle and pregnancy.
Every report comes from a Lived member, sent anonymously.
Have you tried Estradiol for Perimenopause?
Estradiol is a prescription form of estrogen, the main hormone the ovaries make before menopause. Its most common use is menopausal hormone therapy: it treats moderate to severe hot flashes and night sweats, and it treats the vaginal dryness, irritation and painful sex that come from thinning vaginal tissue after menopause. It can also help prevent bone loss after menopause. When bone protection is the only reason for treatment, labels advise considering non-estrogen bone medicines first and reserving estrogen for people at significant risk of osteoporosis. Estradiol also replaces estrogen when the body makes too little of it, for example after both ovaries are removed, when the ovaries stop working early, or with other causes of low sex hormones. Specialists occasionally use it to relieve symptoms of advanced prostate cancer or, in selected patients, metastatic breast cancer. It comes in two broad kinds. Systemic products reach the whole body: tablets, skin patches such as Climara and Vivelle-Dot, gels such as Divigel, and an injection, Delestrogen (estradiol valerate). Low-dose vaginal products, such as Vagifem inserts and Estrace vaginal cream, mainly act where they are placed. When vaginal symptoms are the only problem, a vaginal product is usually considered first. For hot flashes, current US Food and Drug Administration (FDA) labeling notes that the balance of benefit and risk is most favorable when systemic treatment starts before age 60 or within 10 years of menopause.
Estrogen acts on tissues throughout the body, including the brain's temperature control centers, the lining of the vagina and urinary tract, and bone. When estrogen levels fall at menopause, the body's temperature regulation becomes unstable, which produces hot flashes, and the vaginal lining becomes thinner and drier. Bone breakdown also speeds up. Estradiol is chemically the same hormone the ovaries produce, so taking it restores some of the missing estrogen signal. That steadies temperature control, rebuilds vaginal tissue and slows bone loss. Estrogen also stimulates growth of the uterine lining (the endometrium), which is why people who still have a uterus and use systemic estradiol usually need a second hormone, described under warnings, to keep that lining in check.
The form shapes the routine. Tablets are taken by mouth, usually once a day. Patches are worn on clean, dry skin of the lower abdomen or buttock and changed once or twice a week depending on the brand; they should not go on the breasts, and the site should be rotated. Gels are spread on the skin daily and allowed to dry before dressing, followed by hand washing. The injection is given into a muscle by a clinician, at intervals the prescriber sets. Vaginal inserts and cream are usually used daily for about two weeks, then about twice a week. Prescribers generally start at a low dose and adjust it based on symptoms and side effects. Patch, gel, tablet and vaginal doses are not interchangeable milligram for milligram, so follow the instructions for the exact product. For Climara, for example, a patch that falls off can be pressed onto a different spot; if it will not stick, a new patch is applied and the usual change day kept.
Breast tenderness, headache, bloating, nausea and mild swelling are common, especially in the first weeks or after a dose increase, and often settle. Patches can irritate the skin where they sit. Some people have spotting or irregular bleeding early in treatment, particularly with combined hormone regimens. Vaginal bleeding that is new, heavy, persistent or returns after periods have stopped should be reported to the care team promptly, because it needs evaluation to rule out a problem with the uterine lining. A new breast lump, or yellowing of the skin or eyes, also needs prompt assessment. Systemic estrogen raises the risk of blood clots and stroke. Chest pain, sudden shortness of breath or coughing up blood (possible signs of a clot in the lung), or face drooping, arm weakness, trouble speaking, a sudden severe headache or sudden loss of vision (possible signs of a stroke or a clot affecting the eye) are emergencies: call 911. Sudden pain or swelling in one leg needs emergency evaluation the same day.
Systemic estradiol (tablets, patches, gels or injection) used alone increases the risk of cancer of the uterine lining (endometrial cancer) in someone who still has a uterus. Adding a progestogen, a progesterone-type hormone taken as a pill or built into a combination patch or capsule, lowers that risk. People who have had a hysterectomy usually do not need one. Low-dose vaginal products usually do not need a progestogen either, although any unexpected bleeding should still be reported. This endometrial cancer warning remains in the boxed warning of systemic estrogen-alone products. In November 2025 the FDA began removing statements about heart disease, breast cancer and probable dementia from the boxed warnings on menopausal hormone therapy, after reviewing the evidence for people who start treatment around menopause. The underlying risks have not disappeared: the clot and stroke risk described under side effects still applies, especially when treatment starts later in life. Labels also still describe a higher breast cancer risk with longer use, and estrogen is not used to prevent heart disease or dementia. Mammograms and breast checks remain part of care. Estradiol is generally not used by people with current or past breast cancer, other estrogen-sensitive cancers, a past blood clot, stroke or heart attack, liver disease, an inherited clotting disorder, unexplained genital bleeding, or pregnancy. If possible, it is stopped 4 to 6 weeks before surgery that carries a high clot risk or during long periods of immobility. Some medicines change how fast the body clears estrogen. St. John's wort (an herbal supplement), carbamazepine (a seizure medicine) and rifampin (an antibiotic for tuberculosis) can lower estrogen levels and weaken its effect, while some antifungals, HIV medicines and grapefruit juice can raise them. People taking thyroid hormone may need their dose checked after starting estrogen.
Relief from hot flashes usually builds over the first weeks of treatment, and vaginal products work gradually with regular use. Labels suggest reassessing, and considering a lower dose or stopping, every 3 to 6 months. If symptoms do not improve, or side effects are bothersome, the dose, form or regimen can usually be adjusted; for example, a patch or gel is sometimes chosen instead of a tablet. There is no single required stopping date. Prescribers reassess treatment regularly, weighing how much it helps against personal risks such as age, clot history and breast cancer risk. Hot flashes can return after stopping, and some people taper gradually. Routine care usually includes blood pressure checks and mammograms.
Last reviewed • Oct 2026
Educational content, not medical advice.
Hi I started on the .05 bu weekly patches 2 weeks ago. So far my brain fog is better I am sleeping a little bit better but still waking up. Would increasing my dosage help?